
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
BASF has opened its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.